(A) Construction of ahcobB- and ahcobQ-defective strains. M: Marker; Lanes 1 and 3: PCR products of wild-type (WT) using the P7/P8 primer pairs of ahcobB and ahcobQ, respectively; Lanes 2 and 6: PCR …
PDF file containing original PCR for Figure 1A, indicating the relevant bands and treatments.
Original files for PCR analysis displayed in Figure 3D.
(A, B) Homologous and conserved domain analysis of AhCobQ and AhCobB family proteins. (C, D) Dot blot and western blot verified the whole cell protein Kac level among WT, ΔahcobB, and ΔahcobQ …
PDF file containing original western blots for Figure 2C–H, indicating the relevant bands and treatments.
Original files for western blot analysis displayed in Figure 2C–H.
(A) PCR amplification results of ahcobQ, ahcobB, and ahacuC gene, respectively; (B) SDS-PAGE gels of purified recombinant proteins AhCobQ, AhCoB, and AhAcuC, respectively. Lane M represents the DNA …
PDF file containing original PCR and SDS-PAGE for Figure 2—figure supplement 2, indicating the relevant bands.
Original files for PCR and SDS-PAGE analysis displayed in Figure 2—figure supplement 2.
PDF file containing western blots for Figure 2—figure supplement 3, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 2—figure supplement 3.
Purified His-tag (A) and GST-fused (B) recombinant AhCobQ incubated with the substrate Kac-BSA, both in the absence and presence of 150 µM EDTA treatment, respectively.
PDF file containing original western blots for Figure 2—figure supplement 4, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 2—figure supplement 4.
PDF file containing original western blots for Figure 2—figure supplement 5, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 2—figure supplement 5.
(A) Retention time of synthetic peptides YNGVFQECCQAEDKGACLLPK (STD) and YNGVFQECCQAEDKacGACL-L-PK (STD*Kac) with or without AhCobB and AhCoQ treatment; (B) MS1 spectrum of synthetic peptides STD …
Western blot analysis of the lysine acetylases and deacetylases (KDAC) activity of (A) AhCobQ1–179, AhCobQ179–264, AhCobQ1–264, AhCobQ189–264, AhCobQ199–264, AhCobQ195–264, AhCobQ195–255, and AhCobQ2…
PDF file containing original western blots for Figure 4A and C, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 4A and C.
The PCR amplification and SDS-PAGE results of purified recombinant truncated proteins (GST-fusion) 1: AhCobQ1–179; 2: AhCobQ179–265; 3: AhCobQ189–265; 4: AhCobQ189–255; 5: AhCobQ189–250; 6: AhCobQ189…
PDF file containing original PCR and SDS-PAGE for Figure 4—figure supplement 1, indicating the relevant bands.
Original files for PCR and SDS-PAGE analysis displayed in Figure 4—figure supplement 1.
Different colors indicate different branches, and Aeromonas hydrophila spp. is highlighted in red.
(A) Venn diagrams visualized the overlapped upregulated NƐ-lysine acetylation (Kac) proteins and Kac peptides among the ΔahcobB, ΔahcobQ, ΔahacuC, and WT strains. The number of acetylated proteins …
hydrophila ahacuC knockout mutant strain. M: Marker; Lanes 1 and 2: PCR products of wild-type (WT) and ΔahacuC using the P7/P8 primer pairs; Lanes 3 and 4: PCR products of WT and ΔahacuC using the …
PDF file containing original PCR for Figure 6—figure supplement 1, indicating the relevant bands.
Original files for PCR analysis displayed in Figure 6—figure supplement 1.
(A) Mass error distribution of total identified NƐ-lysine acetylation (Kac) peptides; (B–D) Volcano plot of the p-values vs. the log2 Kac peptide abundance differences between ΔahcobQ vs. WT, ΔahcobB…
PDF file containing original western blots for Figure 7, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 7.
1: SUN, 2: ENO, 3 ArcA-2, CK: Kac-BSA, M: prestained protein marker. CK is Kac-BSA as a positive control. The lower section presents the PVDF membrane R350 staining for the loading amount control.
PDF file containing original western blots for Figure 7—figure supplement 1, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 7—figure supplement 1.
The PCR products (right) and SDS-PAGE results of the target recombinant or site-directed acetylated proteins. (A) ArcA-2 and ArcA-2-K26; (B) SUN, SUN-K103, and SUN-K148; (C) ENO and ENO-K195.
PDF file containing original PCR and SDS-PAGE for Figure 7—figure supplement 2, indicating the relevant bands.
Original files for PCR and SDS-PAGE analysis displayed in Figure 7—figure supplement 2.
(A) Western blot verified the deacetylation effect of AhCobQ on ICD and ICD-K388; (B) Western blot verified the deacetylation effect of AhCobQ, AhCobB, and AhAcuC on ICD-K388. The PVDF membrane R350 …
PDF file containing original western blots for Figure 8A and B, indicating the relevant bands and treatments.
Original files for western blots analysis displayed in Figure 8A and B.
Each sample was independently repeated at least three time.
The protein marker located at 70 kDa can be detected easily in Coomassie R-350, while is difficult to display in WB result.
Gene name | Unique peptide | Description | Kac-BSA+AhCobQ intensity | Kac-BSA intensity | BSA intensity |
---|---|---|---|---|---|
cobQ | 11 | CobQ/CobB/MinD/ParA family protein | 2.59E+09 | 0 | 0 |
tuf1 | 7 | Elongation factor Tu | 5.35E+09 | 0 | 0 |
rp/Q | 4 | Large ribosomal subunit protein bL17 | 3.44E+08 | 0 | 0 |
groEL | 3 | Chaperonin GroEL | 1.6E+08 | 0 | 0 |
AHA_3036 | 3 | VWA domain-containing protein | 1.03E+08 | 23562000 | 5005500 |
rpsF | 2 | Small ribosomal subunit protein bS6 | 79780000 | 0 | 0 |
rpsU | 2 | Small ribosomal subunit protein bS21 | 56694000 | 0 | 0 |
rpsB | 2 | Small ribosomal subunit protein uS2 | 47779000 | 0 | 0 |
rpsO | 2 | Small ribosomal subunit protein uS15 | 15869000 | 0 | 0 |
rpsJ | 2 | Small ribosomal subunit protein uS10 | 58784000 | 0 | 0 |
AHA_0497 | 2 | ATP-grasp domain-containing protein | 20711000 | 50345000 | 0 |
AHA_1279 | 2 | Major outer membrane protein OmpAll | 7316100 | 18183000 | 0 |
valS | 2 | Valine--tRNA ligase | 0 | 173130000 | 0 |
aceE | 2 | Pyruvate dehydrogenase E1 component | 74854000 | 0 | 0 |
LC MS/MS of acetylated peptides and materials used in this study.
(a) Selected Kac peptide quantification among Kac-BSA and Kac-BSA incubated with CobQ and BSA without acetylation, by LC MS/MS. (b) Acetylation-modified upregulated proteins of AhCobQ-deleted strains and the identification of residue positions by LC MS/MS. (c) Chemicals and reagents used in this study. (d) Critical commercial assay kits used in this study. (e) Bacterial strains and plasmids used in this study. (f) Primer pairs used in this study.